| |
| |
| Exchange: |
OTC Bulletin Board |
| Security
Type: |
Common |
| Shares
Out: |
149,990,000 |
| Market
Cap: |
137.98(M) |
| Last
Volume: |
394,168 |
Avg
Vol: |
182,850 |
| 52
Week Range: |
$0.9199 - $0.9199 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Lineage Cell Therapeutics is a clinical-stage biotechnology company developing cell therapies. Co. has several allogeneic cell therapy programs in development: OpRegen®, a retinal pigment epithelium cell replacement therapy for the treatment of advanced dry age-related macular degeneration with geographic atrophy; OPC1, an oligodendrocyte progenitor cell therapy for spinal cord injuries; VAC, an allogeneic cancer immunotherapy of antigen-presenting dendritic cells; and other product candidates in preclinical development covering a range of therapeutic areas and target tissues or organs. Co. has rights to HyStem, a patented biomaterial that mimics naturally occurring extracellular matrix.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
96,155 |
6,836,925 |
6,836,925 |
6,836,925 |
| Total Buy Value |
$100,001 |
$7,110,902 |
$7,110,902 |
$7,110,902 |
| Total People Bought |
1 |
3 |
3 |
3 |
| Total Buy Transactions |
1 |
4 |
4 |
4 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Hernandez Alexandra |
Sr Director Finance/Controller |
• – – |
2021-03-30 |
4 |
OE |
$0.69 |
$4,151 |
D/D |
6,000 |
6,000 |
|
- |
|
| Culley Brian M |
President and CEO |
• • – |
2020-12-31 |
4 |
D |
$1.76 |
$9,404 |
D/D |
(5,343) |
185,602 |
|
- |
|
| Culley Brian M |
President and CEO |
• • – |
2020-12-31 |
4 |
OE |
$1.76 |
$27,192 |
D/D |
15,450 |
190,945 |
|
- |
|
| Culley Brian M |
President and CEO |
• • – |
2020-09-30 |
4 |
D |
$0.94 |
$5,004 |
D/D |
(5,343) |
175,495 |
|
- |
|
| Culley Brian M |
President and CEO |
• • – |
2020-09-30 |
4 |
OE |
$0.94 |
$14,470 |
D/D |
15,450 |
180,838 |
|
- |
|
| Culley Brian M |
President and CEO |
• • – |
2020-06-30 |
4 |
D |
$0.87 |
$4,648 |
D/D |
(5,343) |
165,388 |
|
- |
|
| Culley Brian M |
President and CEO |
• • – |
2020-06-30 |
4 |
OE |
$0.87 |
$13,442 |
D/D |
15,450 |
170,731 |
|
- |
|
| Culley Brian M |
President and CEO |
• • – |
2020-03-31 |
4 |
D |
$0.83 |
$4,425 |
D/D |
(5,343) |
155,281 |
|
- |
|
| Culley Brian M |
President and CEO |
• • – |
2020-03-31 |
4 |
OE |
$0.83 |
$12,794 |
D/D |
15,450 |
160,624 |
|
- |
|
| Culley Brian M |
President and CEO |
• • – |
2019-12-31 |
4 |
D |
$0.89 |
$4,755 |
D/D |
(5,343) |
145,174 |
|
- |
|
| Culley Brian M |
President and CEO |
• • – |
2019-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,450 |
150,517 |
|
- |
|
| Culley Brian M |
President and CEO |
• • – |
2019-09-30 |
4 |
D |
$0.98 |
$5,236 |
D/D |
(5,343) |
135,067 |
|
- |
|
| Culley Brian M |
President and CEO |
• • – |
2019-09-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,450 |
140,410 |
|
- |
|
| Culley Brian M |
President and CEO |
• • – |
2019-09-17 |
4 |
D |
$1.00 |
$21,371 |
D/D |
(21,371) |
124,960 |
|
- |
|
| Culley Brian M |
President and CEO |
• • – |
2019-09-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
61,800 |
146,331 |
|
- |
|
| Bradsher Neal C |
Director |
– • • |
2019-08-15 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
34,005,379 |
2.17 |
- |
|
| Bradsher Neal C |
Director |
– • • |
2019-08-15 |
4 |
B |
$0.97 |
$12,717 |
D/D |
13,146 |
34,005,379 |
3.92 |
- |
|
| Bradsher Neal C |
Director |
– • • |
2019-08-14 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
33,992,233 |
2.17 |
- |
|
| Bradsher Neal C |
Director |
– • • |
2019-08-14 |
4 |
B |
$0.98 |
$1,379 |
D/D |
1,407 |
33,992,233 |
3.84 |
- |
|
| Bradsher Neal C |
Director |
– • • |
2019-08-13 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
33,990,826 |
2.17 |
- |
|
| Bradsher Neal C |
Director |
– • • |
2019-08-13 |
4 |
B |
$0.99 |
$9,949 |
D/D |
10,000 |
33,990,826 |
3.84 |
- |
|
| Culley Brian M |
President and CEO |
• • – |
2019-08-13 |
4 |
B |
$1.01 |
$10,100 |
D/D |
10,000 |
84,531 |
2.81 |
- |
|
| Leavitt Chase C. |
General Counsel/Secretary |
• – – |
2019-08-13 |
4 |
B |
$1.02 |
$5,100 |
D/D |
5,000 |
5,000 |
2.74 |
- |
|
| Roberts Brandi |
CFO & SVP, Finance |
• – – |
2019-08-13 |
4 |
B |
$1.01 |
$5,050 |
D/D |
5,000 |
5,000 |
2.74 |
- |
|
| Bradsher Neal C |
Director |
– • • |
2019-04-16 |
4 |
A |
$0.00 |
$0 |
I/I |
0 |
33,980,826 |
|
- |
|
194 Records found
|
|
Page 3 of 8 |
|
|
